Trial Details

TERMINATED
Basic Information
Clinical ID c865
Identifier NCT01716039
Trial Title Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: MTX 12.5|DRUG: MTX 25|DRUG: Adalimumab
Participant Information
Sponsor Alimentiv Inc.
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-06-13
Primary Completion Date 2016-07-18
Completion Date 2016-07-18